FDA Inspection 1325800 — Bioassay - Labor fur biologische Analytik GmbH
The FDA completed an inspection of Bioassay - Labor fur biologische Analytik GmbH on July 13, 2023 in Heidelberg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 13, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Heidelberg (Germany)
Additional Details
Mutual Recognition Agreement (MRA)